✦ LIBER ✦

Concurrent carboplatin (CBDCA) and radiotherapy (RT) for unresectable stage III (Mo) non-small cell lung cancer (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent carboplatin (CBDCA) and Radio

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 146 KB

500 Concurrent low-dose daily carboplati

✍ Yoshida, Y.; Kashiwado, K.; Suenaga, K. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Concurrent daily carboplatin plus thorac

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Phase i/ii study of docetaxel (DOC) and

✍ S. Kato; M. Sakura; T. Kazumoto; H. Sakai; S. Yoneda; Y. Noguchi; K. Kobayashi; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase I study of weekly docetaxel (DTX)

✍ Murakami, H; Kubota, K; Ohe, Y; Watanabe, H; Sawada, M; Akiyama, Y; Kusaba, H; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Neoadjuvant therapy for unresectable sta

✍ Pilstein, D.; Kuten, A.; Daoud, K.; Zen-Al-Deen, I.; Best, L.; Milton, S.; Weile 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB